Tenet Reports Results for the Fourth Quarter and Year Ended December 31, 2018 and Issues Outlook for 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Tenet Healthcare (THC) PT Raised to $29 at RBC Capital
February 27, 2019 7:21 AM ESTRBC Capital analyst Frank Morgan raised the price target on Tenet Healthcare (NYSE: THC) to $29.00 (from $26.00) while maintaining a Sector Perform rating.
... MoreTenet Healthcare (THC) PT Raised to $30 at Baird
February 26, 2019 8:13 AM ESTBaird analyst Matthew Gillmor raised the price target on Tenet Healthcare (NYSE: THC) to $30.00 (from $25.00) while maintaining a Neutral rating following Q4.
... MoreTenet Healthcare (THC) Tops Q4 EPS by 23c, Revenues Beat; Offers FY19 EPS Guidance Above Consensus, FY19 Revenue Mid-Point Views Abvoe Consensus, Provides Q1 EPS/Revenue Outlook
February 25, 2019 4:22 PM ESTTenet Healthcare (NYSE: THC) reported Q4 EPS of $0.51, $0.23 better than the analyst estimate of $0.28. Revenue for the quarter came in at $4.62 billion versus the consensus estimate of $4.51 billion.
Tenet reported net income from continuing operations attributable to Tenet common shareholders of $108 million or $1.04 per diluted share in 2018. In the fourth quarter of 2018, Tenet reported a net loss from continuing operations attributable to Tenet common shareholders of $5 million or $0.05 per diluted share.Adjusted diluted earnings per share from continuing operations was $1.86 in 2018, above the Companys Outlook range of $1.44 to $1.83 and an increase... More